Blood Podcast
Celková doba trvání:
13 h 51 min
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
Blood Podcast
09:35
Review Series on Follicular Lymphoma
Blood Podcast
17:38
Breakthroughs in Multiple Myeloma Treatment and Von Willebrand Disease Mechanisms
Blood Podcast
24:11
Spotlight on Acute Myeloid Leukemia
Blood Podcast
21:39
Busulfan-melphalan conditioning in newly diagnosed, transplant-eligible multiple myeloma; and use of spatial transcriptomics to probe the three-dimensional properties of multiple myeloma bone marrow m
Blood Podcast
13:13
How I Treat Wiskott-Alrich syndrome
Blood Podcast
13:16
Use of Marstacimab for Prophylaxis in hemophilia A and B; matched-donor allogeneic CD19 CAR-T in adult B-ALL; a new prognostic index for T-cell cutaneous lymphomas
Blood Podcast
19:43
Epstein-Barr virus genomic variants in human disease states, somatic GATA1 mutations and leukemia in Down syndrome, and new definitions for high-risk multiple myeloma
Blood Podcast
18:01
Review Series on Acute Lymphoblastic Leukemia (ALL)
Blood Podcast
12:38
Azacitidine holds promise in VEXAS syndrome; a step forward in precision blood matching; identifying a new vulnerability in TP53-mutated AML
Blood Podcast
18:58
Diffuse large B-cell lymphoma’s long-term effects on immune profiles, plasminogen activation and prevention of venous thromboembolism, and PARP inhibitors in hematological malignancies carrying epigen
Blood Podcast
18:31
“Ironing out” Tet2-mutant HSPCs; A CAR-T “license to kill” in T cell leukemia/lymphoma; insights on cHL genetics, through the lens of ctDNA
Blood Podcast
20:43
Targeting NPM1 in AML with a menin inhibitor; in primates, a CD137 ADC eliminates acute GVHD
Blood Podcast
15:10
How I Treat Series on Iron Overload in Hematologic Disorders
Blood Podcast
34:17
Early prediction of follicular lymphoma patients with poor survival; immune hotspots in aplastic anemia; role of allo-transplant for Hodgkin lymphoma in the checkpoint inhibitor era
Blood Podcast
19:49
Exogenous CD19 stimulation in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy, sequential rapid immune-assay in heparin-induced thrombocytopenia diagnosis, and new survival pr
Blood Podcast
18:42
How I Treat series on Acute Myeloid Leukemia
Blood Podcast
42:55
Daratumumab maintenance in newly-diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in myeloproliferative neoplasms; and novel genetic loci associated with the risk of heavy mens
Blood Podcast
15:11
Hematopoietic stem cells with enhanced transplantability, ruxolitinib for refractory macrophage activation syndrome, and magrolimab in newly diagnosed acute myeloid leukemia
Blood Podcast
18:56
A JAK inhibitor for CRS and ICANS prevention; ChAdOx1-platelet interactions and post-vaccination arterial thrombosis; lineage switch, an emerging mechanism of leukemia relapse
Blood Podcast
18:51
Ruxolitinib plus dexamethasone in newly diagnosed adult hemophagocytic lymphohistiocytosis; lysine-specific demethylase-1 inhibitors in sickle cell disease; and clinical characteristics of patients wi
Blood Podcast
18:53
Review series on mantle cell lymphoma
Blood Podcast
17:14
Rapid, high-sensitivity ADAMTS13 assays for TTP; combination CD38/PD-1 blockade in extranodal NK/T-cell lymphoma; a “zombie enzyme” in CREBBP-mutant lymphomas
Blood Podcast
20:08
A novel mouse model of sickle cell SC disease; multiple myeloma induction therapy with isatuximab, carfilzomib, lenalidomide, and dexamethasone; and splicing factor mutations in myelodysplastic syndro
Blood Podcast
19:08
An AI model for transplant risk in myelofibrosis; preventing priapism in men with sickle cell anemia; hallmarks of T cell exhaustion absent in newly diagnosed MM
Blood Podcast
18:24
Social determinants of health and access to allogeneic hematopoietic cell transplantation, megakaryocyte growth factor receptor-based pretransplant conditioning for ex vivo autologous gene therapy, an
Blood Podcast
19:38
Aggressive non-Hodgkin lymphoma: defining and managing high-risk subsets
Blood Podcast
41:28
A key role for T-cell TET3 in chronic GVHD; a BTK inhibitor for ITP; co-inhibition of pre-TCR and IL-7R pathways in a T-ALL patient subset
Blood Podcast
20:30
Special Episode: Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma
Blood Podcast
09:47
How I Treat Series on Geriatric Hematology
Blood Podcast
17:19
Single cell multi-omic analysis of leukemia stem cells, cyclophosphamide for non-immune effector cell-associated neurotoxicity, and glycosylation as a mediator of von Willebrand factor clearance
Blood Podcast
16:06
New insights on PU.1-mutated agammaglobulinemia; venetoclax-based induction therapy in younger AML patients; the link between ABO Blood groups and risk of future VTE
Blood Podcast
19:46
How I Treat Transfusion Medicine (part 2)
Blood Podcast
33:57
Clonal hematopoiesis in frequent blood donors, immune microenvironment and bispecific antibody response in diffuse large B-cell lymphoma, and blinatumomab as part of early consolidation therapy in CD1
Blood Podcast
20:57
How I Treat Transfusion Medicine (part 1)
Blood Podcast
32:12
Discontinuing lenalidomide maintenance in MM; congenital neutropenia syndrome linked to COPZ1 mutations; low GVHD rates with ruxolitinib after allogeneic HCT
Blood Podcast
18:15
Measurable residual disease and maintenance therapy in acute myeloid leukemia (AML), stemness and chemotherapy resistance in AML, and effects of babesiosis on red blood cells in sickle cell disease
Blood Podcast
19:58
Uniquely programmed blood stem cells in the human lung; inclusive molecular classifier for DLBCL; new insights on NETs in the liver vasculature
Blood Podcast
18:12
Phosphoseryl-tRNA kinase inhibition in acute myeloid leukemia (AML), APOE gene variants and post-hematopoietic stem cell transplant outcomes in AML, and the role of chronic inflammation in sickle cell
Blood Podcast
19:06
How I Treat Myeloproliferative Neoplasms
Blood Podcast
38:36
